739 related articles for article (PubMed ID: 18786708)
41. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
Buchwald B; Angersbach D; Jost WH
Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
[TBL] [Abstract][Full Text] [Related]
42. Young- versus older-onset Parkinson's disease: impact of disease and psychosocial consequences.
Schrag A; Hovris A; Morley D; Quinn N; Jahanshahi M
Mov Disord; 2003 Nov; 18(11):1250-6. PubMed ID: 14639664
[TBL] [Abstract][Full Text] [Related]
43. Restless legs syndrome in Parkinson's disease patients may improve with subthalamic stimulation.
Driver-Dunckley E; Evidente VG; Adler CH; Hillman R; Hernandez J; Fletcher G; Lyons MK
Mov Disord; 2006 Aug; 21(8):1287-9. PubMed ID: 16671093
[TBL] [Abstract][Full Text] [Related]
44. Micro lesion effect of the globus pallidus internus and outcome with deep brain stimulation in patients with Parkinson disease and dystonia.
Cersosimo MG; Raina GB; Benarroch EE; Piedimonte F; Alemán GG; Micheli FE
Mov Disord; 2009 Jul; 24(10):1488-93. PubMed ID: 19475579
[TBL] [Abstract][Full Text] [Related]
45. Psychological outcome of patients following treatment of oral cancer and its relation with functional status and coping mechanisms.
Hassanein KA; Musgrove BT; Bradbury E
J Craniomaxillofac Surg; 2005 Dec; 33(6):404-9. PubMed ID: 16253509
[TBL] [Abstract][Full Text] [Related]
46. Falls in Parkinson's disease. Causes and impact on patients' quality of life.
Michałowska M; Fiszer U; Krygowska-Wajs A; Owczarek K
Funct Neurol; 2005; 20(4):163-8. PubMed ID: 16483454
[TBL] [Abstract][Full Text] [Related]
47. The additive effect of co-occurring anxiety and depression on health status, quality of life and coping strategies in help-seeking tinnitus sufferers.
Bartels H; Middel BL; van der Laan BF; Staal MJ; Albers FW
Ear Hear; 2008 Dec; 29(6):947-56. PubMed ID: 18941410
[TBL] [Abstract][Full Text] [Related]
48. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
49. Quality of life and coping strategies among lung transplant candidates and their family caregivers.
Myaskovsky L; Dew MA; Switzer GE; McNulty ML; DiMartini AF; McCurry KR
Soc Sci Med; 2005 May; 60(10):2321-32. PubMed ID: 15748679
[TBL] [Abstract][Full Text] [Related]
50. The impact of symptoms, coping capacity, and social support on quality of life experience over time in patients with lung cancer.
Henoch I; Bergman B; Gustafsson M; Gaston-Johansson F; Danielson E
J Pain Symptom Manage; 2007 Oct; 34(4):370-9. PubMed ID: 17616335
[TBL] [Abstract][Full Text] [Related]
51. Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms.
Klepac N; Hajnsek S; Trkulja V
J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):15-26. PubMed ID: 19996416
[TBL] [Abstract][Full Text] [Related]
52. An update on the treatment of Parkinson's disease.
Jankovic J
Mt Sinai J Med; 2006 Jul; 73(4):682-9. PubMed ID: 16878274
[TBL] [Abstract][Full Text] [Related]
53. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
[TBL] [Abstract][Full Text] [Related]
54. Coping, anxiety and quality of life after coronary artery bypass graft surgery.
Tung HH; Hunter A; Wei J
J Adv Nurs; 2008 Mar; 61(6):651-63. PubMed ID: 18302606
[TBL] [Abstract][Full Text] [Related]
55. Effect of bilateral subthalamic deep brain stimulation on diphasic dyskinesia.
Kim HJ; Lee JY; Kim JY; Kim DG; Paek SH; Jeon BS
Clin Neurol Neurosurg; 2008 Apr; 110(4):328-32. PubMed ID: 18164541
[TBL] [Abstract][Full Text] [Related]
56. Quality of life and depression in Parkinson's disease.
Schrag A
J Neurol Sci; 2006 Oct; 248(1-2):151-7. PubMed ID: 16797028
[TBL] [Abstract][Full Text] [Related]
57. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study.
Smeding HM; Speelman JD; Koning-Haanstra M; Schuurman PR; Nijssen P; van Laar T; Schmand B
Neurology; 2006 Jun; 66(12):1830-6. PubMed ID: 16801645
[TBL] [Abstract][Full Text] [Related]
58. The relevance of anxiety, depression, and coping in patients after liver transplantation.
Nickel R; Wunsch A; Egle UT; Lohse AW; Otto G
Liver Transpl; 2002 Jan; 8(1):63-71. PubMed ID: 11799488
[TBL] [Abstract][Full Text] [Related]
59. Quality of life, coping, and mental health status after living kidney donation.
Wiedebusch S; Reiermann S; Steinke C; Muthny FA; Pavenstaedt HJ; Schoene-Seifert B; Senninger N; Suwelack B; Buyx AM
Transplant Proc; 2009 Jun; 41(5):1483-8. PubMed ID: 19545662
[TBL] [Abstract][Full Text] [Related]
60. Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease.
Aybek S; Lazeyras F; Gronchi-Perrin A; Burkhard PR; Villemure JG; Vingerhoets FJ
Parkinsonism Relat Disord; 2009 Aug; 15(7):521-4. PubMed ID: 19349206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
